MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET
FORECAST & OPPORTUNITIES
FY2016 –FY2026
2
Scope of ReportProduct of Interest (POI): Active Pharmaceutical Ingredient
Review Period
FY2016 – FY2019
Base Year
FY2020
Estimated Year
FY2021
Forecast Period
FY2022 – FY2026
Year Range
Any substance or mixture of substances intended to be used in the manufacture of a drug (medicinal)
product and that, when used in the production of a drug, becomes an active ingredient of the drug
product. Such substances are intended to furnish pharmacological activity or other direct effect in the
diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or function of the
body.
Market Segmentation
REGION
• North
• South
• East
• West
• In-house
• Contract Manufacturing
Organizations
SOURCE
ROUTE OF
ADMINISTRATION
• Oral
• Intravenous
FORM
• Tablet
• Capsules
• Injection
• Others
DISTRIBUTION CHANNEL
• Online
• Offline
THERAPEUTIC
APPLICATION
• Cardiovascular Disease
• Skin Infections
• Neurological Disorders
• Orthopaedic Disorders
• Respiratory
• Gastrointestinal
Disorders
• Bacterial Infections
• Others
END USER
• Adult
• Pediatric
3© TechSci Research
Table of Contents
S. No. Contents Page No
1. Product Overview (Definition of product and major terminologies used in the report)
2.Research Methodology (Detailed description of the methodology used to conduct the research,Raw data backup, list of all secondary sources, List of respondents for primary surveys)
3. Impact of COVID-19 on India Active Pharmaceutical Ingredient Market
4. Executive Summary
5. Manufacturing Active Pharmaceutical Ingredient
5.1. Raw Material
5.2. Machinery
5.3. Manufacturing Methods
5.4. Contact Details of Machinery & Raw Material Supplies
6. India Active Pharmaceutical Ingredient Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1.
By Drug Type (Acyclovir, Amoxicillin, Artesunate, Aspirin, Atorvastatin, Azithromycin, Betamethasone, Carbamazepine, Carbidopa, Cefixime, Cefoperazone, Ceftriaxone, Cephalexin, Ciprofloxacin, Clarithromycin, Clindamycin HCL, Clindamycin Phosphate, Dexamethasone, Diclofenac Sodium, Doxycycline, Erythromycin Stearate/Estolate, Gabapentin, Gentamycin, Levetiracetam, Levodopa, Levofloxacin, Lopinavir, Losartan, Meropenem, Metformin, Metronidazole, Neomycin, Norfloxacin, Ofloxacin, Olmesartan, Ornidazole, Oxcarbazepine, Oxytetracycline, Paracetamol, Piperacillin Tazobactam, Potassium Clavulanate, Pharma API, Rifampicin, Ritonavir, Streptomycin, Sulbactam, Sulfadiazine, Telmisartan, Tetracycline, Tinidazole, Valsartan, Vitamin B1, Vitamin B6)
6.2.2. By Source (In-house v/s Contract Manufacturing Organizations)
6.2.3. By Distribution Channel (Online v/s Offline)
6.2.4.By Therapeutic Application (Cardiovascular Disease, Skin Infections, Neurological Disorders, Orthopaedic Disorders, Respiratory, Gastrointestinal Disorders, Bacterial Infections, Others)
4© TechSci Research
Table of Contents
S. No. Contents Page No
7.2.5. By Form (Tablet, Capsule, Injection, Others)
7.2.6. By Route of Administration (Oral v/s Intravenous)
7.2.7. By End User (Adult v/s Pediatric)
7.2.8. By Region (North, East, West, South)
7.2.9. By Company (FY2020)
7.3. Product Market Map
8. Market Dynamics (This chapter assesses the major demand drivers and restraints.)
8.1. Drivers
8.2. Challenges
9.Market Trends and Developments (This section captures recent trends pertaining tomanufacturing or consumption, market movements in terms of points of production andconsumption, advancements and development)
10. Policy & Regulatory Landscape
10.1. Custom Duty & Taxes
10.2. Government Subsidy & Benefits
10.3. Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)
11. Import & Export Analysis
12. Pricing Analysis
13. Demand and Supply Chain Analysis
14. Pharma API- Pricing and Sourcing Intelligence
15. India Economic Profile
16. Competitive Landscape
16.1. Competition Outlook
16.2. Company Profiles (Top 10 Leading Companies)
5© TechSci Research
Table of Contents
S. No. Contents Page No
16.2.1. Company Details
16.2.2. Product Plants & Capacity
16.2.3. Financials (If Available)
16.2.4. Captive Consumption vs Merchant Sale
16.2.5. Current & Future Plans
17.Strategic Recommendations (Based on the findings of the report strategic recommendations onhow to enter and expand market share)
18. About Us & Disclaimer
RESEARCH METHODOLOGY
7
Research Methodology
✓ Identifying Key Opinion
Leaders
✓ Questionnaire Design
✓ In-depth Interviews
Data Collection
Developing List of Respondents
Formulating Questionnaire
Market Profiling
Data Validation
Data Analysis
In-depth secondary
research was conducted
to determine top
players in the India
active pharmaceutical
ingredient market,
overall market size and
segmental market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a
detailed discussion
guide.
List of industry
players and
industry specialists
was developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as
a result of
primary and
secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel,
statistical tools and
internal proprietary
database to obtain
qualitative and
quantitative insights
about the India active
pharmaceutical
ingredient market.
Data
Collection
Data Filter
& AnalysisResearch &
Intelligence
Actionable
InsightsBusiness
Solution
Primary Research Desk Research Company Analysis
✓ Recent Developments
✓ Market Changing
Aspects/Dynamics
✓ Government Policies
✓ Conclusion
✓ Market Participants
✓ Key Strengths
✓ TechSci Internal
Database
✓ Factiva
✓ Hoovers
Paid Sources
✓ Company Websites
✓ Company Annual
Reports
✓ White Paper Study
✓ Financial Reports
✓ Investor
Presentations
✓ Regulatory Body
✓ Associations, etc.
Secondary Research
Primary Research
8
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of India active pharmaceutical ingredient market. The team has
analyzed the outlook of various segments of this market, while considering the major influencing factors such as growing use of active pharmaceutical
ingredient as an analgesic and antipyretic agent. The study includes market forecasting, which would enable our clients to take better decisions while
planning their strategy to achieve sustainability in India active pharmaceutical ingredient market.
Methodology Followed for Calculation of Market Size:
• Market Size By Value & Volume : Market size, in terms of value, for the year FY2020 was calculated based on information collected through
exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as manufacturers, suppliers, channel partners,
end users, industry experts, and other industry participants.
• The team interviewed more than 40 – 50 manufacturers, suppliers, 180 – 200 end users, and 15 – 20 industry experts and other value & volume chain
stakeholders in the India active pharmaceutical ingredient market to obtain the overall market size from FY2016 to FY2020, which was validated by the
Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during FY2016-
FY2020.
• Respondents were asked about the current and future market growth rates, market shares by source, by product, by form, by route of administration,
by distribution channel, by application, by end user, by region and by company. Removing the outlier responses, the geometric mean of growth
estimates and supplier wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares
generated across various segments were further triangulated from other stakeholders.
9
Research Methodology
Methodology Followed for Calculation of Market Shares:
Market shares by source, by product, by form, by route of administration, by distribution channel, by application, by end user, by region and by
company were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about
the market shares or revenue generated from various segments of active pharmaceutical ingredient market. The final shares were calculated by taking
the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in
SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast India active
pharmaceutical ingredient market, TechSci Research used various forecast techniques such as:
✓ Moving Average
✓ Time Series Analysis
✓ Regression Analysis
✓ Econometric and Judgmental Analysis
10
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used
the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that
the figures compiled are only for the organized market including market share data.
Partial List of Companies Interviewed Key Secondary Sources
▪ Cipla Limited
▪ Dr. Reddy’s Laboratories Ltd.
▪ Intas Pharmaceuticals Ltd.
▪ Cadila Pharmaceuticals Ltd.
▪ Sun Pharmaceutical Industries Limited
▪ Teva Pharmaceuticals Industries Ltd.
▪ Taj Pharmaceuticals Ltd.
▪ GlaxoSmithKline Pharmaceuticals Ltd.
▪ Torrent Pharmaceuticals Ltd.
▪ Fresenius Kabi India Pvt. Ltd.
▪ Indian Pharmaceutical Alliance (IPA)
▪ Indian Drug Manufacturers' Association (IDMA)
▪ Central Drugs Standard Control Organization (CDSCO)
▪ Bulk Drug Manufacturers Association of India (BDMI)
▪ World Bank
▪ TechSci Research Proprietary Database & Knowledge
Repository
▪ Company Annual Reports
▪ Industry Magazines
▪ Industry Reports
▪ News Dailies
▪ Credible Paid Databases
11
Industry Brief
According to TechSci Research report, “Global Active Pharmaceutical Ingredient Market By Type of Synthesis (Biotech (Recombinant Proteins,
Vaccines, Monoclonal Antibodies), Fermentation, Plant Extracts, Synthetic), By Type of Manufacturer (In-house, Contract), By Route of
Administration (Oral, Injectable, Topical), By Route of Administration (Oral, Injectable, Topical), By Therapeutic Application (Cardiovascular
Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, Others), By Region,
Forecast & Opportunities, 2025”, the market is expected to undergo significant CAGR during forecast period owing to increasing prevalence of
chronic diseases such as diabetes, cancer, arthritis, bone & joint infections and pneumonia. The spike in development of new drugs using active
pharmaceutical ingredient to fight against chronic and infectious diseases are also acting as key factors driving the market. Moreover, growth in
biopharmaceutical sector and increasing geriatric population which is more prone to chronic diseases are some other important factors propelling
the growth of global active pharmaceutical ingredient market. With growing advancements in active pharmaceutical ingredient (API)
manufacturing, the market is expected to undergo significant growth in the coming years.
Additionally, the outbreak of COVID-19 and other hospital acquired infections is creating demand for active pharmaceutical ingredient for new
drug developments. They are being extensively used as antibody drug conjugates (ADCs), which are used in combination with monoclonal
antibodies and biologically active drugs for treatment of cancer. Also, increasing number of hospitals and diagnostic centers are supporting the
growth of active pharmaceutical ingredient market.
However, active pharmaceutical ingredient industry is also facing some challenges such as, shortening the drug development time and reducing
the cost of development. Moreover, lack of skilled professionals and limited availability of drugs in the developing nations may hamper the market
growth during the forecast period.
The global active pharmaceutical ingredient market is segmented based on type of synthesis, type of manufacturer, route of administration, type
of drug, therapeutic application and region. Based on type of synthesis, the market is segmented into biotech, fermentation, plant extracts and
synthetic. The biotech segment is further categorized into recombinant proteins, vaccines and monoclonal antibodies. Among them, the synthetic
segment accounted for largest market share in 2019 owing to easier procedures and easy availability of raw materials for the synthesis of active
pharmaceutical ingredient.
Based on type of manufacturer, the global active pharmaceutical ingredient market is segmented into in-house and contract. Among them, the in-
house manufacturer segment is expected to hold largest market share through 2025 as innovator companies are preferring in-house
manufacturing to avail economic benefits and prevent technology leakage.
Major players operating in the global active pharmaceutical ingredient market include Abbott Laboratories, Inc., Teva Pharmaceutical Industries
Ltd., Cipla Inc., Dr. Reddy's Laboratories Ltd., Mylan N.V., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Aurobindo Pharma Ltd,
Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Albemarle Corporation, GlaxoSmithKline Plc, Novartis AG, F. Hoffmann-La Roche AG,
Pfizer Inc., Sanofi, AstraZeneca, Eli Lilly, Aspen and AbbVie Inc. The market players are adopting growth strategies like agreements,
partnerships and collaborations to strengthen their market positions.
“North America dominates the global active pharmaceutical ingredient market followed by Europe as the two regions are witnessing increasing
government focus on generic drugs. Further, increasing technological advancements in manufacturing of APIs is providing lucrative opportunity
for manufacturers in North America. Also, the presence of adequate manufacturing units in developed nations are propelling API market growth,”
said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
12
Sample Data - Snapshot
5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00
10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00 110.00
FY2016 FY2020 FY2021E FY2026F
By Value (USD Million)
By Volume (Million Units)
India Active Pharmaceutical Ingredient Market Size, By Value (USD Million) & Volume (Million Units), FY2016–FY2026F
CAGR By Value & Volume
XX%CAGR By Value & Volume
YY%
India Active Pharmaceutical Ingredient Market Share, By Source,
By Value, 2015–2025F
60%
60%
60%
60%
60%
60%
60%
60%
60%
60%
60%
40%
40%
40%
40%
40%
40%
40%
40%
40%
40%
40%
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021E
FY2022F
FY2023F
FY2024F
FY2025F
FY2026F
In-house Contract Manufacturing Organizations
India Active Pharmaceutical Ingredient Market Share, By End User, By
Value, 2015–2025F
60%
60%
60%
60%
60%
60%
60%
60%
60%
60%
60%
40%
40%
40%
40%
40%
40%
40%
40%
40%
40%
40%
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021E
FY2022F
FY2023F
FY2024F
FY2025F
FY2026F
Adult Pediatric
India Active Pharmaceutical Ingredient Market Share, By Distribution Channel, By Value, 2015–2025F
60%60%60%60%60%60%60%60%60%60%60%
40%40%40%40%40%40%40%40%40%40%40%
FY2016
FY2018
FY2020
FY2022F
FY2024F
FY2026F
Online Offline
13
Report Ordering
License Type Price
Electronic Access - Single User License $2950
Electronic Access - Multi-User License $3750
Custom Research License $7500
Report Price
To View Sample OR Purchase Report
Report Name: INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET
FORECAST & OPPORTUNITIES
FY2016 –FY2026
About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas
to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting
models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and
global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the
market.
Related Reports
• India Streptomycin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule and Injection), By Route of
Administration (Oral v/s Intravenous), By Type of Manufacturing Process (Natural, Synthetic and Semi-synthetic), By Distribution Channel (Online v/s
Offline), By Application (Tuberculosis, meningitis, throat Infection, endocarditis, brucellosis, plague, tularemia, rat bite fever and Others), By End User
(Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026
• India Potassium Clavulanate Market By Composition (Single, Combinational), By Route of Administration (Oral v/s Intravenous), By Form (Tablet,
Capsule, Syrup, Injection), By Distribution Channel (Online v/s Offline), By Source (In-house v/s Contract Manufacturing Organizations), By
Application (Respiratory Tract Infections, Skin Infections, UTI, Otitis media, Gynaecological infections, Bone and Joint Infections and Others), By End
User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or
complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and first hand.
However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results
obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together
with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal
consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.
TechSci Research – North America708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: [email protected]
www.techsciresearch.com
Disclaimer
TechSci Research – Europe54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: [email protected]
www.techsciresearch.com
TechSci Research – Asia-PacificB – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: [email protected]
www.techsciresearch.com